- was
liquidated on 21
February 2023.
Effective 1
February 2024,
Kirill Skrygan replaced Max
Shafirov as CEO. The
following is a non-exhaustive list of...
- Carcinogenesis. 33 (7): 1294–301. doi:10.1093/carcin/bgs179. PMID 22610076. Sand M,
Skrygan M, Sand D,
Georgas D, Hahn SA,
Gambichler T,
Altmeyer P,
Bechara FG (October...
- ISSN 0009-9104. PMC 4837235. PMID 26701127. Hessam, S.; Sand, M.; Gambichler, T.;
Skrygan, M.; Rüddel, I.; Bechara, F.G. (2018). "Interleukin-36 in hidradenitis...
- Science. 53 (7): 3906–12. doi:10.1167/iovs.11-9178. PMID 22562507. Sand M,
Skrygan M, Sand D,
Georgas D, Hahn SA,
Gambichler T,
Altmeyer P,
Bechara FG (October...
- 171–82. doi:10.1189/jlb.1211593. PMID 22581933. S2CID 2220641. Sand M,
Skrygan M, Sand D,
Georgas D, Hahn SA,
Gambichler T,
Altmeyer P,
Bechara FG (October...
- doi:10.1007/s00436-012-2937-3. PMID 22562236. S2CID 14807391. Sand M,
Skrygan M, Sand D,
Georgas D, Hahn SA,
Gambichler T,
Altmeyer P,
Bechara FG (October...
